Abstract:OBJECTIVE:To analyze the prognostic value of hepatocyte growth factor (HGF) and c-met for patients with hepatocellular carcinoma (HCC) after hepatectomy.METHODS:Twenty-five patients undergoing partial hepatectomy for HCC were studied. Serum HGF level was determined using ELISA kit before and after operation respectively. c-met protein and mRNA expression in cancerous and paracancerous tissues were detected by immunohistochemical and RT-PCR methods respectively. The correlations of clinical-pathologic parameters with the HGF level in serum and c-met expression in cancerous tissue were analyzed respectively.RESULTS:HCC patients had a significantly higher concentration of serum HGF than normal controls and chronic hepatitis B respectively [(1.03 +/- 0.09) ng/ml vs (0.69 +/- 0.02) ng/ml and (0.74 +/- 0.09) ng/ml]. No significant difference in serum HGF was observed between HCC and cirrhosis patients with Child-Pugh score B/C [(1.03 +/- 0.09) ng/ml vs (1.04 +/- 0.11) ng/ml]. Serum HGF concentrations were positively correlated with tumor size (> 5 cm), node cirrhosis, portal vein tumor thrombi (PVTT) and preoperative alpha-fetoprotein (AFP) level (> or = 400 microg/L). After the resection of tumor, serum HGF concentration had a peak on the third postoperative day (POD), and then declined, but did not return to normal level on the tenth POD. From preoperative day to third POD, HGF concentration had a higher elevation in patients with major resection than with local resection. Moderately or strongly positive expression of c-met protein was observed in 21 cancerous regions (21/25), and only in 5 paracancerous regions. The intensive expression of c-met mRNA was 100% (25/25) detectable in the cancerous tissues, but only 24% (6/25) in the paracancerous tissues. The expression extent of c-met protein was correlated with portal vein tumor thrombi (PVTT). In paracancerous tissues, the expression of c-met protein was more intense in patients with cirrhosis than those without cirrhosis. The patients with recurrence or metastases after operation had a higher level of serum HGF and more intensive expression of c-met than other patients. No significant association was observed between HGF in serum and c-met expression in cancerous tissue.CONCLUSIONS:The over-expression of HGF and its receptor c-met indicate an adverse prognosis for HCC patients. The sustained high level of serum HGF after hepatectomy may be a factor related to early tumor recurrence and metastasis.

The Evaluative Value of Sema3C and MFN2 Co-Expression Detected by Immunohistochemistry for Prognosis in Hepatocellular Carcinoma Patients after Hepatectomy.

Correlation of nm23 and E-cadherin protein expression with recurrence and metastasis after liver transplantation for hepatocellular carcinoma

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

Overexpression of Semaphorin 3A Promotes Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma after Curative Resection.

Expressions of Nucleoside Diphosphate Kinase (nm23) in Tumor Tissues Are Related with Metastasis and Length of Survival of Patients with Hepatocellular Carcinoma

Expression and Prognostic Impact of NTF3 and TrkC in Hepatocellular Carcinoma.

Prognostic Value of Interleukin 2 and Interleukin 15 in Peritumoral Hepatic Tissues for Patients with Hepatitis B-related Hepatocellular Carcinoma after Curative Resection.

Novel Role of Semaphorin 3A in the Growth and Progression of Hepatocellular Carcinoma.

Prognostic Significance of Combined Α-Fetoprotein and CA19-9 for Hepatocellular Carcinoma after Hepatectomy

[Study on the Prognostic Value of Hepatocyte Growth Factor and C-Met for Patients with Hepatocellular Carcinoma].

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma.

Sema3C promotes hepatic metastasis and predicts poor prognosis in gastric adenocarcinoma

Expression and Prognostic Value of Nuclear RNA Export Factor 3 in Hepatocellular Carcinoma

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection

Serum CHI3L1 Levels Predict Overall Survival of Hepatocellular Carcinoma Patients after Hepatectomy

The Combination of Three Molecular Markers Can Be a Valuable Predictive Tool for the Prognosis of Hepatocellular Carcinoma Patients.

Identification of Biomarkers for Hepatocellular Carcinoma by Semiquantitative Immunocytochemistry

High Expression of VEGF in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Altered distribution and expression pattern of E-cadherin in hepatocellular carcinomas: correlations with prognosis and clinical features.

Relationship Between the Expressions of Coagulation Factor Ⅱ Gene in Hepatocellular Carcinoma and Their Clinical Intexes